Main

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

27 (unknown)

Events

first seen date

2024-03-12 06:12:11

expired found date

-

created at

2024-07-01 20:02:37

updated at

2024-07-01 20:02:37

Domain name statistics

length

14

crc

56641

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

264439665

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

27

mp rejected date

-

mp saved date

-

mp size orig

50654

mp size raw text

6208

mp inner links count

20

mp inner links status

10 (links queued, awaiting import)

Open Graph

title

description

A global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing.

image

site name

author

updated

2026-03-05 14:09:54

raw text

TRANSCENTA HOLDING - A Global Fully Integrated Biotherapeutics Company TRANSCENTA HOLDING - A Global Fully Integrated Biotherapeutics Company Transcenta, Biologics, Antibody, Claudin 18.2 Careers Contact English 简体 English 繁体 About Us Company Profile Mission Leadership Senior Management Board of Directors Scientific Advisory Boards Milestones Sustainability Innovation Discovery Translational Research Process Development Clinical Development Manufacturing Products Pipeline Core products Osemitamab (TST001) TST002 TST003 Scientific Publications Partnering Investors News & Events Press Release In The News Events About Us Company Profile Mission Leadership Senior Management Board of Directors Scientific Advisory Boards Milestones Sustainability Innovation Discovery Translational Research Process Development ...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

1

spam phrases

0

Text statistics

text nonlatin

28

text cyrillic

0

text characters

3445

text words

513

text unique words

282

text lines

137

text sentences

11

text paragraphs

7

text words per sentence

46

text matched phrases

0

text matched dictionaries

0

RSS

rss path

rss status

0 (new)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

0 (new)

sitemap review version

2

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

-

sitemap first import date

-

sitemap last import date

-